Leflunomide leads to inhibition of transendothelial migration

Por Grisar, J, Stummvoll, GH, Smolen, JS
Publicado em 2001

Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study

Por Aletaha, D, Stamm, T, Kapral, T, Eberl, G, Grisar, J, Machold, K, Smolen, J
Publicado em 2003

Increased transendothelial migration of scleroderma lymphocytes

Por Stummvoll, G, Aringer, M, Grisar, J, Steiner, C, Smolen, J, Knobler, R, Graninger, W
Publicado em 2004

Enhanced transendothelial in vitro migration of scleroderma lymphocytes

Por Stummvoll, GH, Aringer, M, Grisar, J, Steiner, CW, Smolen, JS, Knobler, R, Graninger, WB
Publicado em 2001

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Por Miehsler, W, Reinisch, W, Valic, E, Osterode, W, Tillinger, W, Feichtenschlager, T, Grisar, J, Machold, K, Scholz, S, Vogelsang, H, Novacek, G
Publicado em 2004

Leflunomide inhibits transendothelial migration of peripheral blood mononuclear cells

Por Grisar, J, Aringer, M, Koller, M, Stummvoll, G, Eselbock, D, Zwolfer, B, Steiner, C, Zierhut, B, Wagner, L, Pietschmann, P, Smolen, J
Publicado em 2004